The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction.

Enoxaparin therapy and obesity were associated with an increased incidence of a failed cfDNA test due to low FF. Further research is needed to determine the mechanism by which anticoagulation therapy alters cfDNA test functionality and identify approaches to improve test performance in these women.